Type III and type I procollagen markers in fibrosing alveolitis

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 3, 1999, Pages 818-823

  Lammi, Lauri ^a,b   Ryhänen, Lasse ^a,b   Lakari, Essi ^a,b   Risteli, Juha ^a,b   Pääkkö, Paavo ^a,b   Kahlos, Katriina ^a,b   Lähde, Seppo ^a,b   Kinnula, Vuokko ^a,b  

^a VAASA CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PROCOLLAGEN; PROCOLLAGEN TYPE 1 CARBOXYPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DISEASE ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; GAS DIFFUSION; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033034474     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.3.9805060     Document Type: Article

References (34)

1. 1. Prockop, D., K. Kivirikko, L. Tuderman, and N. Guzman. 1979. The biosynthesis of collagen and its disorders. N. Engl. J. Med. 301:13-23.
2. 2. Bateman, E., M. Turner-Warwick, and B. C. Adelman-Grill. 1981. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 36:645-653.
3. 3. Bjermer, L., M. Thunell, and R. Hällgren. 1986. Procollagen III peptide in bronchoalveolar lavage fluid: a potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis. Lab. Invest. 55: 654-656.
4. 4. Bjermer, L., R. Lundgren, and R. Hällgren. 1989. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44:126-131.
5. 5. Lammi, L., V. L. Kinnula, S. Lähde, J. Risteli, P. Pääkkö, E. Lakari, and L. Ryhänen. 1997. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur. Respir. J. 10:2725-2730.
6. 6. Low, R. B., K. R. Cutroneo, G. S. Davis, and M. S. Giancola. 1983. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis. Lab. Invest. 48:755-759.
7. 7. Luisetti, M., A. Bulgheroni, L. Baccella, L. Pasturenzi, and C. Aprile. 1990. Elevated serum procollagen III aminopeptide levels in sarcoidosis. Chest 98:1414-1420.
8. 8. Risteli, J., and L. Risteli. 1995. Analysing connective tissue metabolites in human serum: biochemical, physiological and methodological aspects. J. Hepatol. 22(Suppl. 2):77-81.
9. 9. Pohl, W. R., A. B. Thompson, H. Köhn, S. Losch, H. Umek, E. Legenstein, F. Kummer, S. I. Renard, and H. Klech. 1992. Serum procollagen III peptide levels in subjects with sarcoidosis: a 5-year follow-up study. Am. Rev. Respir. Dis. 145:412-417.
10. 10. Milman, N., M. S. Kristensen, K. Bentsen, G. Grode, and J. Fredriksen. 1995. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. Sarcoidosis 12:38-41.
11. 11. O'Connor, C., K. Ward, A. van Breda. A. McIlgorm, and M. X. Fitz Gerald. 1989. Type 3 procollagen peptide in bronchoalveolar lavage fluid: poor indicator of course and prognosis in sarcoidosis. Chest 96:339-344.
12. 12. Haukipuro, K., L. Risteli, M. I. Kairaluoma, and J. Risteli. 1987. Amino-terminal propeptide of type III procollagen in healing wound in humans. Ann. Surg. 206:752-756.
13. 13. Raedsch, R., A. Stiehl, R. Waldherr, G. Mall, K. Gmelin, R. Gotz, S. Walker, P. Czygan, and B. Kommerell. 1982. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value. Zeitschr. Gastroenterol. 20:738-743.
14. 14. McDonald, J., T. Broeckelmann, M. Matheke, E. Crough, M. Koo, and C. Kuhn. 1986. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. J. Clin. Invest. 78:1237-1244.
15. 1, is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88:6642-6646.
16. 16. Risteli, J., S. Niemi, P. Trivedi, A. P. Mowat, and L. Risteli. 1988. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide human type III procollagen. Clin. Chem. 34:715-718.
17. 17. Melkko, J., S. Niemi, L. Risteli, and J. Risteli. 1990. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin. Chem. 36:1328-1332.
18. 18. Rennard, S., G. Basset, D. Lecossier, K. O'Donnell, P. Pinkston, P. Martin, and R. Crystal. 1986. Estimation of absolute volume of epithelial lining fluid recovered by bronchoalveolar lavage by using urea as an endogenous marker of dilution. J. Appl. Physiol. 60:532-538.
19. 19. Bégin, R., B. Martel, Y. Desmarais, G. Drapeau, R. Boileau, M. Rola-Pleszozynski, and S. Massé. 1986. Fibronectin and procollagen-3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep. Chest 89:237-243.
20. 20. Cavalleri, A., F. Gobba, L. Bacchella, F. Luberto. and A. Ziccardi. 1988. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis. Br. J. Ind. Med. 45:818-823.
21. 21. Schins, R., and P. Borm. 1994. Serum procollagen type III peptide in coal workers' pneumoconiosis: a five year follow up study. Exp. Lung Res. 20:445-455.
22. 22. Cantin, A., R. Boileau, and R. Begin. 1988. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 137:572-578.
23. 23. Harrison, N. K., R. J. McAnulty, W. G. Kimpton, J. R. E. Fraser, T. C. Laurent, and G. J. Laurent. 1993. Heterogeneity of type III procollagen N-terminal peptides in BAL fluid from normal and fibrotic lungs. Eur. Respir. J. 6:1443-1448.
24. 24. Low, R. B., M. S. Giancola, T. E. King, J. Chapitis, P. Vacek, and G. S. Davis. 1992. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 146:701-706.
25. 25. Diot, E., P. Diot, C. Valat, E. Boissinot, E. Asquier, E. Lemarie, and J. Guilmot. 1995. Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma. Eur. Respir. J. 8:1559-1565.
26. 26. Harrison, N., R. McAnulty, P. Haslam, C. Black, and G. Laurent. 1990. Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis. Thorax 45:606-610.
27. 27. Gilligan, D., C. O'Connor, K. Ward, D. Moloney, B. Bresnihan, and M. Fitz Gerald. 1990. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 45:591-596.
28. 28. Kuroki, S., A. Ohta, N. Sueoka, O. Katoh, H. Yamada, and M. Yamaguchi. 1995. Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-γ in progressive patients. Br. J. Rheumatol. 34:31-36.
29. 29. Sutinen, S., H. Riska, R. Backman, S. H. Sutinen, and B. Froseth. 1995. Alveolar lavage fluid in normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. Respir. Med. 89: 85-92.
30. 30. Farjanel, J., D. Hartman, B. Guidet, L. Luquel, and G. Offenstadt. 1993. Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:1091-1099.
31. 31. Clark, J. G., J. A. Milberg, K. P. Steinberg, and L. D. Hudson. 1995. Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann. Intern. Med. 122:17-23.
32. 32. Chesnutt, A. N., M. A. Matthay, F. A. Tibayan, and J. G. Clark. 1997. Early detection of type III procollagen peptide in acute lung injury. Am. J. Respir. Crit. Care Med. 156:840-845.
33. 33. Bachella, L., C. Tinell, L.S. Gigè, V. Peona, C. Aprile, M. Gorrini, L. Pastarenzi, G. Cetta, and M. Luisetti. 1996. Serum type I and type III procollagen peptide levels in sarcoidosis. Eur. Respir. J. 9:1648-1651.
34. 34. Kikuchi, K., H. Ihn, S. Sato, A. Igarashi, Y. Soma, Y. Ishibashi, and K. Takehara. 1994. Serum concentrations of procollagen type I carboxy-terminal propeptidc in systemic sclerosis. Arch. Dermatol. Res. 286: 77-80.